Federal Drug Administration approves Alzheimer’s blood test for use in primary care
1. The FDA has cleared the first Alzheimer’s blood test for community use, marking a pivotal step toward earlier and ...
Tag: Alzheimer’s
The Scan by 2 Minute Medicine®: FDA clears Alzheimer’s blood test, WHO warns of antibiotic resistance, New York confirms chikungunya case, and CDC layoffs raise concern
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. FDA ...
Leqembi gains at home injection for maintenance dosing
1. The FDA cleared a subcutaneous maintenance version of lecanemab, allowing patients with AD (Alzheimer’s disease) to continue treatment at ...
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup- Obesity RNA deal, at-home Alzheimer’s dosing, oncology royalty financing, and first Bruton’s Tyrosine Kinase Inhibitor for Immune Thrombocytopenia [September 3, 2025]
Novo’s srRNA push expands cardiometabolic pipeline On August 28, Novo Nordisk announced a collaboration with Replicate Bioscience to pursue self ...
![2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/Untitled-design-350x250.png)
2MM: AI Roundup –Mental health AI bans, clinical documentation breakthroughs, and Alzheimer’s research prize [August 27th, 2025]
Illinois bans unsupervised AI in mental health care Illinois approved the Wellness and Oversight for Psychological Resources Act, making it ...
Increased rates of unmet social needs observed shortly following a diagnosis of dementia
Discontinuity of social support among US adults with cognitive impairment before and after the confirmed diagnosis of dementia: a matched ...
Eli Lilly: Kisunla was shown to reduce symptoms and slow disease progression in adults with early symptomatic Alzheimer’s disease.
Compared to the placebo, patients treated with Kisunla had a 35% slower cognitive and functional decline at 18 months of ...
The Scan by 2 Minute Medicine®: Tremendous Blood Tests, Protecting Against HIV, Skin Cancer Scare and Health at the Olympics:
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Hormone-modulating therapy decreased risk of dementia in breast cancer patients
1. In a retrospective cohort study of women newly diagnosed with breast cancer, use of hormone therapy was associated with ...
High-sugar dietary pattern associated with increased risk of dementia
Associations of sugar intake, high-sugar dietary pattern, and the risk of dementia: a prospective cohort study of 210,832 participants 1. ...
